What Researchers Did
Researchers conducted a systematic overview of radiation therapy for urinary bladder cancer, synthesizing data from 3 meta-analyses and 33 randomized trials involving 4333 patients.
What They Found
They found moderate evidence of an overall survival benefit with preoperative radiotherapy followed by cystectomy compared to curative radiotherapy, based on early studies conducted between 1964 and 1986. Additionally, a meta-analysis of two studies indicated moderate evidence of a survival benefit at 5 and 10 years and increased local control with hyperfractionated radiotherapy compared to conventional fractionation.
What This Means for Canadian Patients
Canadian patients with urinary bladder cancer may benefit from modern hyperfractionated radiotherapy, which showed improved survival at 5 and 10 years and better local control. However, conclusions from older studies on preoperative radiotherapy may not directly apply to current treatment practices due to significant advancements in surgical and radiation techniques.
Canadian Relevance
This study has no direct Canadian connection as it was conducted by The Swedish Council of Technology Assessment in Health Care (SBU).
Study Limitations
A key limitation is that conclusions from early studies may not be relevant to modern treatment due to significant advancements in techniques, and data was insufficient to determine optimal fraction dose.